RG
Retirement Group Portfolio holdings
AUM
$279M
This Quarter Return
-0.63%
1 Year Return
+22.21%
3 Year Return
+33.69%
5 Year Return
–
10 Year Return
–
AUM
$240M
AUM Growth
+$240M
(-0.12%)
Cap. Flow
+$19.3M
Cap. Flow
% of AUM
8.04%
Top 10 Holdings %
Top 10 Hldgs %
56.16%
Holding
841
New
35
Increased
159
Reduced
145
Closed
64
Top Buys
| 1 |
Invesco S&P 500 Top 50 ETF
XLG
|
$17.7M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.12M |
| 3 |
Chevron
CVX
|
$866K |
| 4 |
Invesco QQQ Trust
QQQ
|
$865K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$846K |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$2.16M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
$1.74M |
| 3 |
PIMCO Dynamic Income Fund
PDI
|
$1.13M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
$1.02M |
| 5 |
SPDR Gold Trust
GLD
|
$964K |
Sector Composition
| 1 | Financials | 23.11% |
| 2 | Energy | 9.15% |
| 3 | Technology | 4.12% |
| 4 | Industrials | 2.5% |
| 5 | Consumer Discretionary | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
iShares MSCI EAFE Growth ETF
EFG
$13.1B
| – | – | -57 | Closed | -$5.47K |
|
827
iShares ESG Aware MSCI EM ETF
ESGE
$5.09B
| – | – | -149 | Closed | -$4.71K |
|
828
Fidelity Total Bond ETF
FBND
$20.3B
| – | – | -1,100 | Closed | -$50K |
|
829
Gannett
GCI
$603M
| $0 | ﹤0.01% | +15 | New | – |
|
|
GMRE
830
Global Medical REIT
GMRE
$502M
| – | – | -730 | Closed | -$6.67K |
|
831
Goldman Sachs
GS
$226B
| – | – | -36 | Closed | -$11.6K |
|
832
Huntington Bancshares
HBAN
$26B
| – | – | -145 | Closed | -$1.56K |
|
|
HES
833
DELISTED
Hess
HES
| – | – | -43 | Closed | -$5.85K |
|
834
iBio
IBIO
$16.1M
| – | – | -285 | Closed | -$174 |
|
835
iShares US Utilities ETF
IDU
$1.65B
| – | – | -49 | Closed | -$4.01K |
|
836
iShares Core 10+ Year USD Bond ETF
ILTB
$574M
| – | – | -78 | Closed | -$14.6K |
|
837
iShares MSCI Intl Momentum Factor ETF
IMTM
$3.19B
| – | – | -210 | Closed | -$6.97K |
|
838
ING
ING
$70.3B
| – | – | -366 | Closed | -$4.93K |
|
839
Intuit
INTU
$186B
| – | – | -21 | Closed | -$9.62K |
|
840
Iovance Biotherapeutics
IOVA
$807M
| – | – | -1,000 | Closed | -$7.04K |
|